Franz Baudenbacher

USPTO Granted Patents = 16 (Patent Applications = 10)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 122(Granted Patents)

Location History:

Franklin, TN (US) (2008 - 2020)
Nashville, TN (US) (2006 - 2024)

Company Filing History:

12 out of 1,153

Vanderbilt University

patents

3 out of 2,483

Baxter International Inc.

4. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11950890 - System and method for monitoring and determining patient parameters from sensed venous waveform (2024-04-09),

2. 11039754 - System and method for monitoring and determining patient parameters from sensed venous waveform (2021-06-22),

3. 11039753 - System and method for monitoring and determining patient parameters from sensed venous waveform (2021-06-22),

4. 10531799 - Intravenous access device detecting intravenous infiltration and in-vein placement (2020-01-14),

5. 10456046 - Device and method for hemorrhage detection and guided resuscitation and applications of same (2019-10-29),

6. 10179083 - Compression device, system, and method for decreasing abdominal venous pooling (2019-01-15),

7. 10082500 - Device and method for detecting a target analyte (2018-09-25),

8. 8003378 - Capillary perfused bioreactors with multiple chambers (2011-08-23),

9. 7981649 - Device and methods for monitoring the status of at least one cell (2011-07-19),

10. 7977089 - Bioreactors with multiple chambers (2011-07-12),

11. 7790443 - Bioreactors with substance injection capacity (2010-09-07),

12. 7713733 - Device and methods for detecting the response of a plurality of cells to at least one analyte of interest (2010-05-11),

13. 7704745 - Apparatus and methods for monitoring the status of a metabolically active cell (2010-04-27),

14. 7534601 - Capillary perfused bioreactors with multiple chambers (2009-05-19),

15. 7435578 - Device and methods for monitoring the status of at least one cell (2008-10-14),

Title: Franz Baudenbacher: Innovator in Patient Monitoring Technologies

Introduction

Franz Baudenbacher is a notable inventor based in Franklin, TN (US), recognized for his significant contributions to the field of medical technology. With a total of 16 patents to his name, he has developed innovative systems and methods that enhance patient monitoring and care.

Latest Patents

Baudenbacher's latest patents focus on a system and method for monitoring and determining patient parameters from sensed venous waveforms. These devices, systems, and methods are designed to monitor patient hemodynamic status, systemic vascular resistance, and various respiratory metrics. By measuring peripheral venous pressure, his inventions can detect changes or problems related to patient blood volume. The transformation of peripheral venous pressure measurements from the time domain to the frequency domain allows for advanced analysis. This includes identifying heart rate frequencies and evaluating harmonics to determine conditions such as hypovolemia or hypervolemia, as well as assessing systemic vascular resistance and respiratory effort.

Career Highlights

Throughout his career, Baudenbacher has worked with prestigious organizations, including Vanderbilt University and Baxter International Inc. His work has significantly impacted the medical field, particularly in improving patient monitoring technologies.

Collaborations

Baudenbacher has collaborated with esteemed colleagues such as John P. Wikswo and David Edward Cliffel, contributing to the advancement of medical technology through teamwork and shared expertise.

Conclusion

Franz Baudenbacher's innovative work in patient monitoring technologies exemplifies the importance of advancements in medical care. His contributions continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.